{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:38:39Z","timestamp":1769607519270,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Leading Leukemia Research (LEUKA) charity","award":["06\/Q0406\/47"],"award-info":[{"award-number":["06\/Q0406\/47"]}]},{"name":"National Institute for Health Research Biomedical Research Center Funding Scheme"},{"name":"Imperial College High Performance Computing Service"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jmoldx.2015.09.005","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T08:15:22Z","timestamp":1454660122000},"page":"176-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients"],"prefix":"10.1016","volume":"18","author":[{"given":"Mary","family":"Alikian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ellery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Gerrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Kasperaviciute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alona","family":"Sosinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra S.","family":"Whale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Milojkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Apperley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim F.","family":"Huggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Foroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair G.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2015.09.005_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1309\/AJCPUN89CXERVOVH","article-title":"Chronic myelogenous leukemia, BCR-ABL1+","volume":"132","author":"Vardiman","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1200\/JCO.2011.34.7146","article-title":"Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008","volume":"29","author":"Bjorkholm","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.2012.48.5797","article-title":"Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease","volume":"32","author":"Rousselot","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2013-02-483750","article-title":"Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study","volume":"122","author":"Ross","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib8","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1016\/j.ejca.2013.06.018","article-title":"Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)","volume":"49","author":"Thielen","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/asheducation-2011.1.136","article-title":"Minimal residual disease and discontinuation of therapy in chronic myeloid leukemia: can we aim at a cure?","volume":"2011","author":"Melo","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2011.08603.x","article-title":"Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia","volume":"153","author":"Foroni","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ajh.21457","article-title":"Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia","volume":"84","author":"Foroni","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib12","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1111\/j.1751-553X.2010.01236.x","article-title":"Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA","volume":"32","author":"Bartley","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2009-11-255109","article-title":"In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib","volume":"116","author":"Sobrinho-Sim\u00f5es","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib14","first-page":"186","article-title":"An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders","volume":"8","author":"Cross","year":"1994","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"10.1016\/j.jmoldx.2015.09.005_bib15","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1007\/s00277-015-2315-1","article-title":"Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization","volume":"94","author":"Cross","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib16","first-page":"10","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnetjournal"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib17","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv (1303.3997) 2013 http:\/\/arxiv.org\/abs\/1303.3997"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nmeth.1628","article-title":"CREST maps somatic structural variation in cancer genomes with base-pair resolution","volume":"8","author":"Wang","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nmeth.1363","article-title":"BreakDancer: an algorithm for high-resolution mapping of genomic structural variation","volume":"6","author":"Chen","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib20","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2013new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1101\/gr.229202","article-title":"BLAT\u2013the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2144\/04372ST03","article-title":"AutoDimer: a screening tool for primer-dimer and hairpin structures","volume":"37","author":"Vallone","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib24","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/ac103230c","article-title":"Evaluation of digital PCR for absolute DNA quantification","volume":"83","author":"Sanders","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajh.21954","article-title":"Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies","volume":"86","author":"Gerrard","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ajh.23212","article-title":"Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonization","volume":"87","author":"Gerrard","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib29","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer Program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-1-4939-0733-5_2","article-title":"Minimum information necessary for quantitative real-time PCR experiments","volume":"1160","author":"Johnson","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/7.5.767","article-title":"The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia","volume":"7","author":"Jeffs","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib32","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/leu.2010.174","article-title":"Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation","volume":"24","author":"Score","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib33","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/leu.2010.185","article-title":"Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR","volume":"24","author":"Ross","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2009-11-255109","article-title":"In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib","volume":"116","author":"Sobrinho-Simoes","year":"2010","journal-title":"Blood"},{"issue":"6 Pt 1","key":"10.1016\/j.jmoldx.2015.09.005_bib35","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1111\/j.1751-553X.2010.01236.x","article-title":"Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA","volume":"32","author":"Bartley","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2353\/jmoldx.2009.080150","article-title":"Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis","volume":"11","author":"Mattarucchi","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib37","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.V87.6.2588.bloodjournal8762588","article-title":"Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation","volume":"87","author":"Zhang","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmoldx.2014.10.002","article-title":"A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemia","volume":"17","author":"Bartley","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib39","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/gm191","article-title":"Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET","volume":"2","author":"Shibata","year":"2010","journal-title":"Genome Med"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2257.2002.00470.x","article-title":"Efficiency of interphase fluorescence in situ hybridization for BCR\/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings","volume":"24","author":"Akel","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib42","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1158\/1078-0432.CCR-07-0844","volume":"13","author":"Branford","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib43","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.blre.2005.01.008","article-title":"Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia","volume":"20","author":"Hughes","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/10428194.2011.555569","article-title":"Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay","volume":"52","author":"Goh","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib46","doi-asserted-by":"crossref","first-page":"e58177","DOI":"10.1371\/journal.pone.0058177","article-title":"Methods for applying accurate digital PCR analysis on low copy DNA samples","volume":"8","author":"Whale","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib47","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/nar\/gks203","article-title":"Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation","volume":"40","author":"Whale","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2015.09.005_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jmoldx.2013.10.007","article-title":"Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR","volume":"16","author":"Jennings","year":"2014","journal-title":"J Mol Diagn"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157815002652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157815002652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:45:56Z","timestamp":1576241156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157815002652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1525157815002652"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.09.005","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}